| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963263 | Vaccine | 2015 | 8 Pages |
Abstract
RV1 vaccine was highly effective to prevent rotavirus hospitalizations and emergency visits among children <3 years of age in a high-income setting with its predominant use. Our estimates were similar to high-income settings with concurrent RV1 and pentavalent vaccine use.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Margaret K. Doll, David L. Buckeridge, Kathryn T. Morrison, Arnaud Gagneur, Bruce Tapiero, Hugues Charest, Caroline Quach,